SCHEMBL19993530

SCHEMBL19993530

C=C/C(=C\C)c1cc(C(=O)NC2CC2)ccc1C

nearest known ligand 0.49

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MAPK14 Q16539 11/20 0.49
KIT P10721 1/20 0.46
MAPK11 Q15759 4/20 0.46
HSPB1 P04792 1/20 0.46
CYP2C9 P11712 1/20 0.46
NPC1 O15118 3/20 0.45
RAB9A P51151 3/20 0.45
SMN1; SMN2 Q16637 2/20 0.45
TP53 P04637 2/20 0.45
TSHR P16473 1/20 0.45
CYP1A2 P05177 1/20 0.43
HPGD P15428 1/20 0.43
CYP2C19 P33261 1/20 0.43
LCK P06239 1/20 0.43
CSF1R P07333 1/20 0.43
KDR P35968 1/20 0.43
CNR2 P34972 2/20 0.43
POLB P06746 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19993538 0.85 MAPK14 (0.34) MAPK14KITMAPK11HSPB1CYP2C9
SCHEMBL19993520 0.80 MAPK14 (0.50) MAPK14KITMAPK11HSPB1CYP2C9
SCHEMBL19993497 0.77 HDAC8 (0.39) NPC1RAB9ASMN1; SMN2HPGD
SCHEMBL10282601 0.77 GLA (0.64) MAPK14MAPK11HSPB1CYP2C9NPC1
SCHEMBL23591986 0.76 MAPK11 (0.60) MAPK14MAPK11
SCHEMBL14308374 0.75 MAPK14 (0.50) MAPK14MAPK11HSPB1CYP2C9NPC1
SCHEMBL14048887 0.75 MAPK14 (0.48) MAPK14KITMAPK11HSPB1CYP2C9
SCHEMBL2948427 0.74 MAPK14 (0.58) MAPK14MAPK11HSPB1CYP2C9NPC1
SCHEMBL25548 0.74 MAPK14 (0.58) MAPK14MAPK11HSPB1CYP2C9NPC1
SCHEMBL15653186 0.73 MAPK14 (0.54) MAPK14MAPK11HSPB1CYP2C9NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018052772-A1 HETEROARYL CARBOXAMIDE COMPOUNDS AS INHIBITORS OF RIPK2 BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2018-03-22 WO disclosed